Triple
T18784284
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Notch |
E459333
|
entity |
| Predicate | requiresProcessingBy |
P82893
|
FINISHED |
| Object | ADAM-family metalloprotease |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ADAM-family metalloprotease | Statement: [Notch, requiresProcessingBy, ADAM-family metalloprotease]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ADAM-family metalloprotease Context triple: [Notch, requiresProcessingBy, ADAM-family metalloprotease]
-
A.
MT1-MMP (via BT1718)
MT1-MMP (via BT1718) is a membrane-bound matrix metalloproteinase exploited by the Bicycle Therapeutics drug candidate BT1718 as a tumor-targeting antigen for selective delivery of cytotoxic payloads to cancer cells.
-
B.
ase
"ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
-
C.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
D.
Serpins
Serpins is a civil parish in the municipality of Lousã in central Portugal, known for its natural landscapes and proximity to the Serra da Lousã.
-
E.
ACE2
ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: ADAM-family metalloprotease Target entity description: ADAM-family metalloproteases are membrane-anchored enzymes that cleave and activate various cell-surface proteins, playing key roles in processes such as cell signaling, development, and inflammation.
-
A.
MT1-MMP (via BT1718)
MT1-MMP (via BT1718) is a membrane-bound matrix metalloproteinase exploited by the Bicycle Therapeutics drug candidate BT1718 as a tumor-targeting antigen for selective delivery of cytotoxic payloads to cancer cells.
-
B.
ase
"ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
-
C.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
D.
Serpins
Serpins is a civil parish in the municipality of Lousã in central Portugal, known for its natural landscapes and proximity to the Serra da Lousã.
-
E.
ACE2
ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8d396f54c8190ba49db31e8743842 |
completed | April 10, 2026, 10:40 a.m. |
| NER | Named-entity recognition | batch_69e5977ffa648190be5f682bba47fb0a |
completed | April 20, 2026, 3:03 a.m. |
Created at: April 10, 2026, 11:52 a.m.